title: Commentary: tackling the challenges of developing targeted therapies for cancer.
authors.affiliation: Section of Hematology-Oncology, University of Chicago, Chicago, Illinois 60637, USA. rschilsk@medicine.bsd.uchicago.edu
authors.forename: Richard L
authors.initials: RL
authors.lastname: Schilsky
authors.forename: Jeff
authors.initials: J
authors.lastname: Allen
authors.forename: Joshua
authors.initials: J
authors.lastname: Benner
authors.forename: Ellen
authors.initials: E
authors.lastname: Sigal
authors.forename: Mark
authors.initials: M
authors.lastname: McClellan
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents